Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03105453
Other study ID # 2016/220
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 2016
Est. completion date November 2, 2020

Study information

Verified date November 2020
Source Universitair Ziekenhuis Brussel
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To assess the impact of the female genital microbiome on ART outcome.


Description:

The main objective of this study is to learn more about which microbial spectra are negatively or positively impacting IVF pregnancy outcome. This information is needed before proceeding to the next step in which an adaptation of the microbiome can be attempted to improve IVF outcome. The study is expected to shed light over the possible influence of the microbiome on causes for subfertility, endometrial receptivity and obstetrical complications. A diagnostic link may be found with entities that are often unexplained today, e.g. (recurrent) miscarriage and repeated implantation failure.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date November 2, 2020
Est. primary completion date November 2, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: 1. Caucasian women 2. Women undergoing an in-vitro fertilization cycle (for the first or second time) 3. Single embryo transfer 4. Day 5 embryo transfer 5. Gonadotropin-releasing hormone antagonist 6. Anti-mullerian hormone > 0,69 and < 3,5 µg/L 7. Body mass index = 30 kg/m2 8. Signed informed consent Exclusion Criteria: 1. Women suffering of chronic diseases which may impair pregnancy outcome (e.g. diabetes, chronic renal disease). 2. Antibiotics within 3 weeks of sampling 3. Surgical sperm retrieval 4. In-vitro maturation 5. Preimplantation genetic diagnosis 6. Grade 3 or 4 endometriosis 7. Patients unable to comprehend the investigational nature of the proposed study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
3 Sampling points
When entering the in-vitro fertilization/intracytoplasmatic sperm injection 4 samples will be harvested: a rectal swab, a cervical swab, a vaginal swab and an intra-uterine sample using an empty embryo catheter. After the ovarian stimulation treatment, the same patients will be sampled two more times: once at the moment of oocyte retrieval (rectal, cervical, vaginal and intra-uterine samples) and again just before the embryo transfer (at this stage, the embryo culture medium will be harvested, as well as an intra-uterine sample using the tip of an empty embryo inner catheter before the embryo transfer and a rectal sample)

Locations

Country Name City State
Belgium Universitair Ziekenhuis Brussel Brussels

Sponsors (1)

Lead Sponsor Collaborator
Universitair Ziekenhuis Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical pregnancy To determine if there Is there a association between the microbiome profile and pregnancy outcome after ART 7 weeks
Secondary Baseline microbiome profile Descriptive analysis of the microbiome present in women suffering of infertility 1 week
Secondary Variation of microbiome profile during assisted reproductive technologies Descriptive analysis of the microbiome present in women suffering of infertility according to the assisted reproductive technologies cycle stage 5 weeks
Secondary Microbiome profile of the embryo culture Descriptive analysis of the microbiome present in the embryo culture on the day of embryo transfer 1 week
Secondary Live birth To determine if there Is there a association between the microbiome profile and pregnancy outcome after assisted reproductive technologies 43 weeks
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A

External Links